Gottlieb joins Illumina’s board; plus Kiniksa, Frequency, DBV, VectivBio and more

Former FDA Commissioner Scott Gottlieb joined the board of next-generation sequencing company Illumina Inc. (NASDAQ:ILMN). The new role is at least his fourth board appointment since stepping down from the agency last year. Along with his roles as a partner at New Enterprise

Read the full 430 word article

How to gain access

Continue reading with a
two-week free trial.